Search

Your search keyword '"Respiratory Muscles pathology"' showing total 177 results

Search Constraints

Start Over You searched for: Descriptor "Respiratory Muscles pathology" Remove constraint Descriptor: "Respiratory Muscles pathology"
177 results on '"Respiratory Muscles pathology"'

Search Results

1. Nrf2 Deficiency Exacerbates the Decline in Swallowing and Respiratory Muscle Mass and Function in Mice with Aspiration Pneumonia.

2. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis.

3. Weighing Antitumor Immunity against Life-threatening Myocarditis from Immune-Checkpoint Inhibitors.

4. Epidemiological analysis of intramuscular hemorrhage of respiratory and accessory respiratory muscles in fatal drowning cases.

5. An autopsy case of anti-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy with involvement of the heart, lungs and respiratory muscles.

6. Early Inflammation in Muscular Dystrophy Differs between Limb and Respiratory Muscles and Increases with Dystrophic Severity.

7. Chest wall muscle atrophy as a contributory factor for forced vital capacity decline in systemic sclerosis-associated interstitial lung disease.

8. Ultrasound-Guided Minimally Invasive Autopsy of Respiratory Muscles as a Safe and Cost-Effective Technique in COVID-19 Pandemic Era.

9. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.

10. Desmin and dystrophin abnormalities in upper airway muscles of snorers and patients with sleep apnea.

11. The efficiency of inspiratory muscle training in patients with ankylosing spondylitis.

12. Aspiration pneumonia induces muscle atrophy in the respiratory, skeletal, and swallowing systems.

13. Depleted iron stores are associated with inspiratory muscle weakness independently of skeletal muscle mass in men with systolic chronic heart failure.

14. Skeletal, cardiac, and respiratory muscle function and histopathology in the P448Lneo- mouse model of FKRP-deficient muscular dystrophy.

15. Evaluation of Skeletal Muscle Function in Lung Transplant Candidates.

17. The emerging phenotype of late-onset Pompe disease: A systematic literature review.

18. Practical Recommendations for Diagnosis and Management of Respiratory Muscle Weakness in Late-Onset Pompe Disease.

19. Evidence of hypoxic tolerance in weak upper airway muscle from young mdx mice.

20. Functional impact of sarcopenia in respiratory muscles.

21. Natural History of Cardiac and Respiratory Involvement, Prognosis and Predictive Factors for Long-Term Survival in Adult Patients with Limb Girdle Muscular Dystrophies Type 2C and 2D.

22. Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: New insights from a comparative study by MRI and respiratory function assessment.

23. Implication of Sarcopenia and Sarcopenic Obesity on Lung Function in Healthy Elderly: Using Korean National Health and Nutrition Examination Survey.

24. Postural vital capacity difference with aging in duchenne muscular dystrophy.

25. Respiratory muscle weakness in the Zucker diabetic fatty rat.

26. Early life exposure to chronic intermittent hypoxia causes upper airway dilator muscle weakness, which persists into young adulthood.

27. Work of breathing in children with diffuse parenchymal lung disease.

28. Phenotype of matrin-3-related distal myopathy in 16 German patients.

29. [Ca2+]i oscillations in ASM: relationship with persistent airflow obstruction in asthma.

30. The dynamics of respiratory muscle changes during the progression of chronic obstructive pulmonary disease.

31. [Inflammatory myopathy with initial respiratory muscles involvement and rheumatoid arthritis].

32. Impact of Bacillus Calmette-Guérin Moreau vaccine on lung remodeling in experimental asthma.

33. Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function.

34. Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets.

35. The physiological basis of rehabilitation in chronic heart and lung disease.

36. Diaphragm and ventilatory dysfunction during cancer cachexia.

37. Mitochondrial DNA deletions and depletion within paraspinal muscles.

38. Fluoxetine may worsen hyperoxia-induced lung damage in neonatal rats.

39. Injury of peripheral muscles in smokers with chronic obstructive pulmonary disease.

40. [Inclusion body myositis, Paget's disease of the bone and frontotemporal dementia: early involvement of the heart and respiratory muscles].

41. Skeletal muscle abnormalities in chronic heart failure.

42. Puzzling dyspnea caused by respiratory muscle weakness.

43. Rib cage deformities alter respiratory muscle action and chest wall function in patients with severe osteogenesis imperfecta.

44. [Reduction of muscle mass mediated by myostatin in an experimental model of pulmonary emphysema].

45. Haemorrhages into the back and auxiliary breathing muscles after death by hanging.

46. Spinal respiratory motoneurons and interneurons.

47. Effects of loading on upper airway and respiratory pump muscle motoneurons.

48. Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD.

49. Exacerbation of pathology by oxidative stress in respiratory and locomotor muscles with Duchenne muscular dystrophy.

50. Respiratory muscle dysfunction and training in chronic heart failure.

Catalog

Books, media, physical & digital resources